Abstract
We evaluated a novel psoralen-inactivated dengue virus type 1 (DENV-1) vaccine candidate in Mus musculus mice. Mice received intradermal alum or 5 to 10 ng of psoralen-inactivated virus. Anti-DENV-1 neutralizing antibody was detectable in 10/11 mice receiving a 10-ng dose at 90 days. Psoralen-inactivated DENV-1 is immunogenic in mice.
Original language | English |
---|---|
Pages (from-to) | 304-306 |
Number of pages | 3 |
Journal | Clinical and Vaccine Immunology |
Volume | 17 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2010 |
Externally published | Yes |